2918D Taubman Center - 1500 E. Medical Center
Ann Arbor, Michigan 48109
Available to mentor
Dr. Geoffrey Siegel is a Michigan native who received his Medical Doctorate Degree at the Detroit Medical Center and his residency in Orthopaedic Surgery at Wayne State University. After finishing his fellowship in Orthopaedic Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, he joined the Department of Orthopaedic Surgery at the University of Michigan as Clinical Assistant Professor.
Dr. Siegel's clinical interests are in the treatment of benign and malignant disease, both metastatic as well as primary bone cancer in adults and children. His surgical interests include limb salvage and complex musculoskeletal reconstruction. He enjoys both resident and community physician education in the field of Musculoskeletal Oncology.
Clinical Interests:
- Treatment of benign and malignant disease
- Both metastatic and primary bone cancer in adults and children
Pubmed
-
2025 Mar 10;PresentationVideo, Papers, Education & Research (VIPER): Musculoskeletal Oncology I Papers: Metastatic disease, reconstruction
-
Hooper RC, Kelly B, Cederna PS, Siegel G. Phys Med Rehabil Clin N Am, 2024 Nov; 35 (4): 725 - 737.Journal ArticleAmputation Surgery: Review of New and Emerging Techniques.
DOI:10.1016/j.pmr.2024.06.001 PMID: 39389633 -
Siegel GW. 2024 Oct 30;PresentationSoft Tissue Sarcomas
-
Siegel GW. 2024 Feb 15;PresentationMake PVNS a thing of the past! Treat Tenosynovial Giant Cell Tumor (TGCT) instead
-
Siegel GW. 2024 Feb 15;PresentationMake PVNS a thing of the past! Treat Tenosynovial Giant Cell Tumor (TGCT) instead
-
Chen Z, Akanbi F, Lucas DR, Walton DM, Benavides E, Soki FN, Siegel GW, McCauley LK, Clines GA. J Bone Miner Res, 2024 Mar 22; 39 (2): 79 - 84.Journal ArticleA skeleton in a huff: insights in etiologies of osteosclerosis.
DOI:10.1093/jbmr/zjad021 PMID: 38477819 -
Brodsky CN, Bucala MD, Abdulfatah EM, Siegel GW. Am J Clin Oncol, 2023 Apr 1; 46 (4): 172 - 177.Journal ArticleExtraskeletal Myxoid Chondrosarcoma: Retrospective Case Series Examining Prognostic Factors, Treatment Approaches, and Oncologic Outcomes.
DOI:10.1097/COC.0000000000000988 PMID: 36825763 -
Brodsky CN, Bucala MD, Abdulfatah EM, Siegel GW. Am J Clin Oncol, 2023 Apr 1; 46 (4): 172 - 177.Journal ArticleExtraskeletal Myxoid Chondrosarcoma: Retrospective Case Series Examining Prognostic Factors, Treatment Approaches, and Oncologic Outcomes.
DOI:10.1097/COC.0000000000000988 PMID: 36825763